[Clinical evaluation of a new bronchodilator (terbutaline sulfate) in bronchial asthma].
D000403:Airway Resistance / Q000187:drug effects; D000605:Amino Alcohols / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002082:Butylamines / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D009921:Metaproterenol / Q000627:therapeutic use; D010627:Phenethylamines / Q000009:adverse effects / Q000627:therapeutic use*; D011674:Pulse / Q000187:drug effects; D012118:Resorcinols / Q000627:therapeutic use; D013147:Spirometry; D014797:Vital Capacity / Q000187:drug effects
D000605:Amino Alcohols; D001993:Bronchodilator Agents; D002082:Butylamines; D010627:Phenethylamines; D012118:Resorcinols; D009921:Metaproterenol